A comprehensive understanding of potential material change can mitigate its impact on patient safety.
Andrew Feilden
Advertisement
Andrew Feilden is the European E&L strategic director for Element.
Articles by Andrew Feilden
By understanding potential material change, the impact on patient safety can be understood and mitigated.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
France Remains One of Europe’s Leading Biotech Funding Hubs
3
CPHI Milan Future Leader Award Winner: Pauline van der Wijst-Janssen
4
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
5